Join the Zepbound group to help and get support from people like you.
Zepbound News (Page 5)
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
THURSDAY, Nov. 7, 2024 – Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could...
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
TUESDAY, Nov. 5, 2024 – Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover t...
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
THURSDAY, Oct. 31, 2024 – A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds...
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
FRIDAY, Oct. 25, 2024 – As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds....
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
THURSDAY, Oct. 24, 2024 – Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year in the United States, a new study...
FDA Medwatch Alert: FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize
October 2, 2024 -- The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection ...
Weight-Loss Meds Like Wegovy, Ozempic Could Battle Alcoholism
THURSDAY, Oct. 17, 2024 – Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking...
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
TUESDAY, Oct. 15, 2024 – For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
TUESDAY, Oct. 15, 2024 – Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to...
GLP-1 Weight-Loss Meds, Wegovy, Zepbound, Won't Raise Teens' Suicide Risk, May Even Lower It
MONDAY, Oct. 14, 2024 – As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide...
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds, Wegovy, Zepbound, for Employees
WEDNESDAY, Oct. 9, 2024 – When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance...
GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy
TUESDAY, Oct. 1, 2024 – Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy. Now, research finds this scenario is...
Cost Has Many Going Around Doctors to Get Weight-Loss Meds
WEDNESDAY, Sept. 17, 2024 – Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often too expensive to afford without insurance c...
Weight-Loss Drug Zepbound May Work Better in Women Than Men
THURSDAY, Sept. 12, 2024 – The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All...
Taking Wegovy, Zepbound? One Expert Has Dietary Advice
TUESDAY, Sept. 3, 2024 – Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health. But they still need to eat a high-quality diet if they want to m...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Obstructive Sleep Apnea/Hypopnea Syndrome